| Project No. |
Project |
Main Project Principal Investigator |
Affiliation |
Execution Period |
| AS-IDR-110-03 |
Automated antibody technological platform with synthetic antibody libraries for antibody-based therapeutics and diagnostics of human diseases |
An-Suei Yang |
Genomics Research Center |
2021/1/1~2022/12/31 |
| AS-IDR-110-02 |
Development of new drugs against COVID-19 and related viral diseases |
Po-Huang Liang |
Institute of Biological Chemistry, Institute of Chemistry, |
2021/1/1~2023/12/31 |
| AS-IDR-110-05 |
Insight the role of pseudaminic acid and biofilme on Acinetobacter baumannii virulence |
Shih-Hsiung Wu |
Institute of Biological Chemistry |
2021/1/1~2023/12/31 |
| AS-IDR-110-01 |
Development of bi-specific mAbs for the treatment of acute viral infections |
Shie-Liang Hsieh |
Genomics Research Center, Institute of Cellular and Organismic Biology, Institute of Molecular Biology |
2021/1/1~2024/12/31 |
| AS-IDR-110-06 |
Characterization of mycobacteriophages as potential tools for the diagnosis and treatment of mycobacterial diseases |
Todd Lowary |
Institute of Biological Chemistry, National Taiwan University, National Cheng-Kung University |
2021/1/1~2024/12/31 |
| AS-IDR-110-07 |
Understanding gastrointestinal symptoms caused by SARS-CoV-2 infection and identifying therapeutic targets using colonic organoids derived from colorectal cancer patients' specimen and crypt stem cells |
Chia-Ning Shen |
Genomics Research Center, National Taiwan University, CHANG GUNG MEMORIAL HOSPITAL |
2021/1/1~2024/12/31 |
| AS-IDR-110-04 |
Development of therapeutic monoclonal antibodies for emerging infectious diseases by single B cell technology |
Kuo-I Lin |
Genomics Research Center, Institute of Cellular and Organismic Biology, Biodiversity Research Center |
2021/1/1~2025/12/31 |
| AS-IDR-111-01 |
Peptidomimetics approach in redesigning antimicrobial peptide with extended stability and activity against multidrug resistant bacteria |
Jyh-Yih Chen |
Institute of Cellular and Organismic Biology |
2022/1/1~2025/12/31 |
| AS-IDR-111-02 |
Design for virus-like particle vaccine against emerging SARS-CoV-2 variants by mammalian cell line production scheme |
Pei-Wen Hsiao |
Agricultural Biotechnology Research Center, Institute of Biological Chemistry |
2022/1/1~2025/12/31 |
| AS-IDR-113-02 |
Unveiling the exploitation of intracellular vesicles and membranous organelles in the SARS-CoV-2-infected cells by a versatile deep profiling platform for the cellular vesicle landscape |
I-Hsuan Wang |
Institute of Biomedical Sciences |
2024/1/1~2025/12/31 |
| AS-IDR-114-S06 |
Innovative Research and Response to Emerging Infectious Diseases: From Pathogen Surveillance to Prevention and Treatment |
Shin Ru Shih |
Biomedical Translation Research Center |
2025/2/1~2025/12/31 |